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Abstract 
Mammalian kidney is known to express a transport system specific for small peptides and pharmacologically active 
aminocephalosporins. This system is energized by a transmembrane electrochemical H + gradient. Recently, a H +-coupled peptide 
transporter has been cloned from rabbit and human intestine (Fei et al. (1994) Nature 368, 563-566; Liang et al., J. Biol. Chem., in 
press). Functional studies have established that the renal peptide transport system is similar but not identical to its intestinal counterpart. 
Therefore, in an attempt to isolate the renal H +/peptide cotransporter cDNA, we screened a human kidney eDNA library with a probe 
derived from the rabbit intestinal H +/peptide cotransporter DNA. This has resulted in the isolation of a positive clone with a 2190 bp 
long open reading frame. The predicted protein consists of 729 amino acids. Hydropathy analysis of the amino acid sequence indicates the 
presence of twelve putative transmembrane domains. The primary structure of this protein exhibits 50% identity and 70% similarity to the 
human intestinal H +/peptide cotransporter. Functional expression of the kidney cDNA in HeLa ceils results in the induction of a 
H +-coupled transport system specific for small peptides and aminocephalosporins. Reverse transcription-coupled polymerase chain 
reaction demonstrates that the cloned transporter is expressed in human kidney but not in human intestine. This transporter, henceforth 
called PEPT 2, represents a new member in the growing family of H +-coupled transport systems in the mammalian plasma membrane. 
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Mammalian kidney expresses a transport system that is 
specific for small peptides consisting of 2-4 amino acids 
[1-4]. The physiological role of the transport system is to 
absorb amino nitrogen from the tubular filtrate in the form 
of small peptides. The pharmacological relevance of this 
transporter is the recognition of fl-lactam antibiotics and 
other peptide-like drugs as its substrates [5-7]. Due to its 
role in the reabsorption of these compounds, the trans- 
porter is an important component in determining the half- 
life of these pharmacologically active drugs in the circula- 
tion and hence holds great potential for therapeutic appli- 
cations. The driving force for the transporter is a trans- 
membrane lectrochemical H + gradient [4,8]. A H +-cou- 
pled peptide transport system is also expressed in the 
mammalian small intestine where it functions in the ab- 
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sorption of peptides and fl-lactam antibiotics [9,10]. Func- 
tional studies however have established that the renal 
peptide transport system is similar but not identical to its 
intestinal counterpart [11-13]. Recently, we have isolated 
a eDNA encoding a H +-coupled peptide transporter f om 
the small intestine of the rabbit [14] and the human [15]. 
Here we report the cloning of a H +-coupled peptide 
transporter from human kidney. This transporter is ex- 
pressed in the kidney but not in the small intestine. This 
kidney-specific peptide transporter, designated as PEPT 2, 
represents a new member in the growing family of H + 
coupled transport systems. 
A human kidney Agtl0 eDNA library, obtained from 
Graeme Bell, University of Chicago, was screened by 
plaque hybridization using VCS 257 host cells. The probe 
was a 560 bp fragment released from the 5' end coding 
region of the rabbit intestinal peptide transporter DNA by 
digestion with AflIII and HindIII. The probe was labeled 
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with [a  -32 P]dCTP using the oligolabeling kit from Phar- 
macia. Hybridization was carried out at 35 ° C in a solution 
containing 50% formamide, 6 × SSC, 5 × Denhardt's solu- 
tion, 0.1% SDS and 100 /zg /ml  of salmon sperm DNA. 
Washing was done under low stringency conditions. Posi- 
tive clones were identified and plaque-purified by sec- 
ondary and tertiary screening. 
Digestion of the phage DNA from the positive clone 
1 C GAGGAGAGAGAGAGAGTAAGGAGC CAGCCATGAATC CTTT  C CAGAAAAATGAGTC AAG 60 
M N P F Q K N E S K 
61 GAAACTCTTTTTTCACCTGTCTCCATTGAAGAGGTACCACCTCGACCACCTAGCCCTCCA 120 
E T L F S P V S I E E V P P R P P S P P 
121 AAGAAGCCATCT C CGACAATCTGTGGCTC AACTATC CACTGAGCATTGC CTTCATTGTG 180 
K K P S P T I C G S N Y P L S I A F I V 
181 GTGAATGAATTCTGCGAGCGCTTTTC TATTATGGAATGAAAGCTGTGCTGATC TGTAT 240 
V N E F C E R F S Y Y G M K A V L I L Y 
241 TT  CCTGTATTTCCTGCACTGGAATGAAGATACCTCCACATCTATATAC CATGC CTTCAGC 300 
F L Y F L H W N E D T S T S I Y H A F S 
301 AGCCT CTGTTATTTTACTC C CATC CTGGGAGCAGCCATTGCTGACTCGTGGTTGGGAAAA 360 
S L C Y F T P I L G A A I A D S W L G K 
361 TTCAAGACAATCATCTATCTC TC CTTGGTGTATGTGCTTGGC ATGTGATCAAGTCCTTG 420 
F K T I I Y L S L V Y V L G H V I K S L 
421  GGTGCCTTACCAATACTGGGAGGACAAGTGGTACACACAGTCCTATCATTGAT CGGCCTG 480 
G A L P I L G G ~ V V H T V L S L I G L 
481  AGTCTAATAGCTTTGGGGACAGGAGGCATCAAACC CTGTGTGGCAGC TTTTGGTGGAGAC 540 
S L I A L G T G G I K P C V A A F G G D 
541 CAGTTTGAAGAAAAACATGCAGAGGAACGGACTAGATACTT C CAGTCTT C TACCTGTC C 600 
Q F E E K H A E E R T R Y F S V F Y L S 
601 ATCAATGCAGGGAGCTTGATTTCTACATTTATCACAC CATGCTGAGAGGAGATGTGCAA 660 
I N A G S L I S T F I T P M L R G D V Q 
661 TGTTTTGGAGAAGACTGCTATGCATTGGCTTTTGGAGTTCCAGGACTGCTCATGGTAATT 720 
C F G E D C Y A L A F G V P G L L M V I 
721 GCACTTGTTGTGTTTGCAATGGGAAG CAAAATATACAATAAACCAC CC C CTGAAGGAAAC 780 
A L V V F A M G S K I Y N K P P P E G N 
781 ATAGTGGCTCAAGTTTT  CAAATGTATCTGGTTTGCTATTTC CAATCGTTTCAAGAAC CGT 840 
I V A Q V F K C I W F A I S N R F K N R 
841 T CTGGAGACATTC CAAAGCGACACGACTGGCTAGACTGGGCGGCTGAGAAATATC CAAAG 900 
S G D I P K R H D W L D W A A E K Y P K 
901 CAGCTCATTATGGATGTAAAGGCACTGAC AGGGTACTATTC CTTTATAT C CCATTGC CC 960 
Q L I M D V K A L T R V L F L Y I P L P 
961 ATGTTCTGGGCTCTTTTGGATCAGCAGGGTTCACGATGGAC TTTGCAAG CCATCAGGATG 1020 
M F W A L L D Q Q G S R W T L Q A I R M 
1021 AATAGGAATTTGGGGTTTTTTGTGCTTCAGCCGGAC AGATGCAGGTTCTAAATC C CTT  1080 
N R N L G F F V L Q P D Q M ~ V L N P L 
1081 CTGGTTCTTATCTTCATCCCGTTGTTTGACTTTGTCATTTATCGTCTGGTCTCCAAGTGT 1140 
L V L I F I P L F D F V I Y R L V S K C 
1141 GGAATTAACTTCT CATCACTTAGGAAAATGGCTGTTGGTATGATC TAGCATGC CTGGCA 1200 
G I N F S S L R K M A V G M I L A C L A 
1201 TTTGCAGTTGCGGCAC GTGTAGAGATAAAAATAAATGAAATGGC C C CAGCC CAGCCAGGT 1260 
F A V A A R V E I K I N E M A P A Q P G 
1261 C C CCAGGAGGTTTTC CTACAAGTCTTGAAT CTGGCAGATGATGAGGTGAAGGTGACAGTG 1320 
P Q E V F L Q V L N L A D D E V K V T V 
1321 GTGGGAAATGAAAACAATTCTCTGTTGATAGAGTC CATCAAATCCTTTCAGAAAACACCA 1380 
V G N E N N S L L I E S I K S F Q K T P 
1381 CACTATTC CAAAC TGCACCTGAAAACAAAAAGC AGGATTTTCACTTCCACCTGAAATAT 1440 
H Y S K L H L K T K S Q D F H F H L K Y 
1441 CACAATTTGTCT CTCTACACTGAGCATTCTGTGCAGGAGAAGAACTGGTACAGTCTTGTC 1500 
H N L S L Y T E H S V Q E K N W Y S L V 
1501 ATTCGTGAAGATGGGJuKCAGTATCTC CAGCATGATGGTAAAGGATACAGAAAGCAGAACA 1560 
I R E D G N S I S S M M V K D T E S R T 
1561 AC CAATGGGAT GACAACCGTGAGGTTTGTTAACACTTTGCATAAAGATGTCAACATCTC C 1620 
T N G M T T V R F V N T L H K D V N I S 
1621 CTGAGTACAGATAC CTCTCT CAATGTTGGTGAAGACTATGGTGTGTC TGCTTATAGAACT 1680 
L S T D T S L N V G E D Y G V S A Y R T 
1681 GTGCAAAGAGGAGAATAC  CTGCAGTGCACTGTAGAACAGAAGATAAGAACTTTTCTCTG 1740 
V Q R G E Y P A V H C R T E D K N F S L 
1741 AATTTGGGTCTTCTAGACTTTGGTGCAGCATATCTGTTTGTTATTACTAATAACACCAAT 1800 
N L G L L D F G A A Y L F V I T N N T N 
1801 CAGGGT CTTCAGGC CTGGAAGATTGAAGACATTCCAGC AACAAAATGTC CATTCGGTGG 1860 
Q G L Q A W K I E D I P A N K M S I R W 
1861 CAGCTACCACAATATGC C CTGGTTACAGCTGGGGAGGTCATGTTCTCTGTCACAGGTCTT 1920 
Q L P Q Y A L V T A G E V M F S V T G L 
1921 GAGTTTTCTTATTCTCAGGCTCCCTCTAGCATGAAATCTGTGCTCCAGGCAGCTTGGCTA 1980 
E F S Y S Q A P S S M K S V L ~ A A W L 
1981 TTGACAATTG CAGTTGGGAATAT CATCGTGCTTGTTGTGGCACAGTTCAGTGGC CTGGTA 2040 
L T I A V G N I I V L V V A Q F S G L V 
2041 CAGTGGGCCGAATTCATTTTGTTTTCCTGCCTCCTGCTGGTGATCTGCCTGATCTTCTCC 2100 
Q W A E F I L F S C L L L V I C L I F S 
2101 AT  CATGGGCTACTACTATGTTC CTGTAAAGACAGAGGATATGCGGGGTC CAGCAGATAAG 2160 
I M G Y Y Y V P V K T E D M R G P A D K 
2161 CACATTC CTCACATCCAGGGGAACATGATCAAACTAGAGAC CAAGAAGACAAAACTCTGA 2220 
H I P H I Q G N M I K L E T K K T K L * 
2221 TGACTCCCTAGATTCTGTCCTAACCCCAATTCCCTGGCCCTGTCTTGAAGCATTTTTTTT  2280 
2281 CTTCTACTGGATTAGACAAGAGAGATAGCAGCATAT CAGAGCTGATCTCCTCCACCTTTC 2340 
2341 T CCAATGACAGAAGTTC CAGGACTGGTTTTCCAGTACAT CTTTAAACAAGGCC C CAGAGA 2400 
2401 CTCTATGTCTGC CCGTC CATCAGTGAACTCATTAAA CTTGTGCAGTGTTGCTGGAGCTG 2460 
2461 GCCTGGTGTCTC CAAATGAC CATGAAAATACACACGTATAATGGAGATCATTCT CTGTGG 2520 
2521 GTATGCAAAGTTATGGGAATT C CTTTATAGGTAACTGC CATTTAGGACTGATGGC CTAA 2580 
2581 TTTTTGAGGTGCTGATTTAGAGGCAAAATTGCAGAATAACAAAGAAATGGTATTTCAAGT 2640 
2641 TTTTTTTTTTATAAGCAAT GTAATTATGCTATT CACAGGGGC CG 2685 
Fig. 1. Nucleotide sequence of the human kidney H +/peptide cotransporter (PEPT 2) cDNA and the predicted amino acid sequence. Putative 
transmembrane domains are underlined. 
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with EcoRI yielded four fragments, 1,85, 0.5, 0.2, and 
0.15 kb in size. The digestion pattern indicated that there 
were three internal EcoRI sites in the cDNA insert and 
that the size of the full-length insert was approx. 2.7 kb. In 
order to obtain the full-length cDNA insert for subsequent 
subcloning and functional expression, the phage DNA was 
subjected to partial digestion with EcoRI. This procedure 
yielded five new fragments (2.7, 2.5, 2.35, 2.0 and 0.65 kb 
in size) in addition to the above-described four fragments. 
Attempts to subclone the 2.7 kb fragment into pBluescript 
SKII were not successful. However, we succeeded in 
subcloning the 2.5 kb fragment into this vector. The 
fragments arising from complete digestion with EcoRI 
were also subcloned into pBluescript SKII for nucleotide 
PEPT 2 1 MNPFQE]RES3JS','bFSPVSIEEVPPRPPSPPKKPSPTICGSNYPLSIAFIV 50 
• i-- : .lllll Ill 
PEPT I 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ]IGM~KSHSFFGEPLSIFFIV 20 
51 VNEF~SYEt: 'd IKAVLILYFLYFLHWNEDTSTSIYHAFSSLCEFTPILG I00 
lJ Iflllillli'l:llill I: I::: il-ill-i -ili:JilIi 
21 VNEFCERFSYY(~L IL~:F - 'R~' ISWDDNLSTAIYRTFV~TPILG 70 
1oi ~UADS"L~,~'LSL~XS~LP IL~ ........ W 1,1 
I llllIIlIIll: il:II-:l:.:-I::.: I-:: -I 
71 AL IADSWLGI t r~ 'L ' I 'VSLS~IGQAVTSVSSIRDLTD~DSLPV 120 
142 HTVLSL IGLSL~I ]~CVAAFGGDQFE~k~i IYFSVFYLS I  191 
f- lil l l i-li l l l lfll l l i l.l l lfll l l l :--:l.l:II:lil.l 
iRl HVVLSL I~IALGTGGIKPCVSAFGGDQFEEGQEKQRIqRFFSIF 'ZLAI  170 
192 IqAGSL ISTF I~GEfVQCF. .GEDCYALAFGVP~VVFAMGS 239 
II II:il:IIIIIl-: .: :-ll'lIIiII: li-:li:II.:ll 
171 NAGSLLSTIITPMLRVQQCGIHSKQACYPLAFGVPAAI,MAVALIVFVLGS 220 
240 K IY IqKPPP~AQVFKCIWFAIS Iq~GDIPERHDWLDWAAEKYp 289 
: .I -i:lll::.i Ill lII-lll::ll .:llf..lilll I11- 
221 ( ;R (YKK IeKPQ~CIGFAIENRFRHRSKAFPK I~W~XD 270 
• • . ° • 
290 KQL IMDVKALTRVLFLY IP~~RWTLQAIRMNRRLGFFVL  339 
--I ::I "llI:l l l l l I l l l I I I:l l l l l l l I I l l- I- -'I : " 
271 ERL ISQI lqMVTRVMFLY IP~SRWTLQATTMSGKIGALE I  320 
• • • • • 
340 QPI)QMQVL]RPLLVLIFIPLFDFVIYRLVSKCGINFSSLRKMAV(~IILACL 389 
llIlll-:l::l::l:-l:ll l:I-l:-lll-il. II:lllIll:li:: 
321 QP~LIV~IFDAVLYPL IAKCGFRFTSLK I~V(~M 370 
390 AFAVAARVEIKINEMAI)AQPGPQEVFLQVLNLADDEVKVTVVGNENNSLL 439 
If-Ill l::-I-'- I- I - - I I  : - I I I ' " : - : - : - : - l :  
371 AFVVAAIVQVE IDKTLPVFPKGNEVQ I ~  G;q l~ S LP GE ...... 414 
440 IESIKSFQKTPHYS]rr.RT.~:II~SQDFHFHI~SL~TJ~ISVQEIQqWYSL 489 
: - : - : - I  : - : - : -  I : : :  • : -  I : -  I : - : - - I  
415 ~PMSQTNAPRrI 'FDVN.KLTRINISSPGSPVTAVTDDFKQG.QIqu~T,.  462 
490 VI~SISS]ItVKDT.ESRTTNGh'--- '~rVIFEIJS[KDVNISLSTDTSI~ 538 
:::--.: : l l l - :  :...I --:lillI::. :-I-:I... I 
463 LVWAPI~. . .YQVVKDGLNQKPEKG]mqGIRFV]RTFNELITITMSG~AN 509 
: :  - f - . i . l  . . . .  I - . : .11  : - - :1  - l : l i .  II : : :  
510 IS . SYIqASTYQFFPSGIKGFTISSTEIPPQCQPIqFNTFYLEFGSAYTYIV 558 
° • • • 
586 TIq]RTJ~QG~;~WKII[DIPAHIQESII~.WQLPQYALVTAG~SVTGLEFSYS 635 
---: - :-- :Ill-If-:-: :I:lll l:I-IIl:IllIIIIIIIl 
I l i l - I l i l l l l - l i l l : l l l l l l l l : l l .  : . :  I l i l : l i l - - i l l l  
609 QAPSNI~'L~AGWLLTVAVG~IIVLIVAGAGQFSKQWAEYILFA~T.r.T.V 658 
° • . • 
685 I CL I F S I ~ ~  ~.-,'~MRGPADK~I PHI  Q4~R]KIKL~J.-~u~.-rrJ., * . . . .  730  
: l : I I - i l :  : I -  : - - - : :  : -  I -  : : - - : l l  . . . .  : 
659 VCVIFA I ]~ I ]RPAE IEAQFDE ..... D~T.RKS I I I )YPMSGAN 703 
Fig. 2. Comparison of amino acid sequence between the human intestinal (PEPT 1) and kidney (PEPT 2) H +/peptide cotransporters. Solid lines denote 
identical amino acids and dots denote conserved amino acid substitutions. 
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sequencing. Complete sequencing of these fragments and 
comparison of the predicted amino acid sequence with that 
of the human intestinal H +/peptide transporter nabled us 
to determine the order of alignment of the EcoRI frag- 
ments in the kidney cDNA insert. The 5' end of the insert 
was the 0.2 kb fragment followed by 1.85 kb, 0.5 kb, and 
0.15 kb fragments. Thus, the 2.5 kb clone lacked the 5' 
end 0.2 kb fragment. 
We used the following strategy to obtain the 2.7 kb 
full-length clone. Two PCR primers, one corresponding to
the 5' end of the cDNA insert (upstream primer) with an 
adaptor containing the site for XhoI and the other corre- 
sponding to a region located approximately in the middle 
of the 1.85 kb fragment (downstream primer) were de- 
signed. With these primers and the phage DNA as the 
template, a 0.9 kb PCR product was obtained. This product 
and the 2.5 kb clone in pBluescript SKII were digested 
with XhoI and NsiI and the full-length clone was con- 
structed from the resultant fragments. This cDNA was 
under the control of the T7 promotor in the vector, suitable 
for expression in HeLa cells using the vaccinia virus 
expression system. 
Sequencing was done by the dideoxy chain termination 
method [16]. Synthetic oligonucleotide primers were used 
whenever necessary to complete the sequencing of both 
the sense and the antisense strands. Sequence analysis was 
performed by the software package GCG version 7.B 
(Genetics Computer Groups, Madison, WI). Sequence 
alignment was done using the GenBank program GAP. 
The cDNA was functionally expressed in HeLa cells 
using the vaccinia virus expression system [17] as de- 
scribed previously [18,19]. HeLa cells were first infected 
with a recombinant (VTF7. 3) vaccinia virus encoding T7 
RNA polymerase and then transfected with the cDNA 
construct or empty vector. After 8-10 h following trans- 
fection, uptake of radiolabeled glycylsarcosine (30 /xM), 
glycine (50 nM) or proline (50 nM) was measured. The 
uptake medium was 25 mM Mes/Tris (pH 6.0) or 25 mM 
Hepes/Tris (pH 8.0) containing 140 mM NaC1, 5.4 mM 
KC1, 1.8 mM CaC12, 0.8 mM MgSO4, and 5 mM glucose. 
The incubation time for uptake measurements was 3 min. 
For RT-PCR, two sets of PCR primers were designed 
based on the nucleotide sequences of the cloned human 
kidney cDNA and the human intestinal H +/peptide co- 
transporter (PEPT 1) cDNA. The kidney cDNA-specific 
primers corresponded to nucleotide positions 900-917 and 
1760-1777 of the cDNA and the PEPT 1 cDNA-specific 
primers corresponded to nucleotide positions 342-360 and 
1575-1592 of the cDNA. The specificity of each pair of 
primers was established by PCR using respective cDNAs 
as templates. RNA samples derived from human kidney 
(cortex) and human small intestine (jejunum) were sub- 
jected to RT-PCR with each set of these primers and the 
products were analyzed by agarose gel electrophoresis. 
The full-length cDNA, designated as PEPT 2, is 2685 
bp long with an open reading frame of 2190 bp (including 
termination codon) (Fig. 1). The initiation codon is in a 
Kozak consensus sequence, GCCATGA [20]. The coding 
sequence is flanked by a 30 bp long sequence on the 5' end 
and a 465 bp long sequence on the 3' end. The cDNA is 
predicted to code for a protein consisting of 729 amino 
acids. The encoded protein is expected to have a core 
molecular size of 81940 Da and an isoelectric point of 
8.26. Hydropathy analysis of the amino acid sequence 
according to Eisenberg et al. [21], keeping the transmem- 
brane domains to 20-23 residues/span, identifies the pres- 
ence of 12 transmembrane domains, with a long hy- 
drophilic segment (~ 165 amino acids) between the trans- 
membrane domains 9 and 10. There are three putative 
N-glycosylation sites in this exoplasmic hydrophilic seg- 
ment. There are five potential sites for protein kinase 
C-dependent phosphorylation, but no site for protein ki- 
nase A-dependent phosphorylation. Comparison of the 
amino acid sequence between the kidney clone (PEPT 2) 
and the human intestinal H +/peptide cotransporter (PEPT 
1) reveals significant homology, with 50% identity and 
70% similarity (Fig. 2). PEPT 2 is 21 amino acids longer 
than PEPT 1. The extent of similarity is much higher in 
transmembrane domains than in the large hydrophilic loop 
carrying the N-glycosylation sites and in the amino- and 
carboxy-termini. 
To establish the identity of PEPT 2 as a H +/peptide 
cotransporter, the clone was functionally expressed inHeLa 
cells using the vaccinia virus expression system. The 
H +/peptide cotransporter activity was measured by deter- 
mining the uptake of the hydrolysis-resistant dipeptide 
glycylsarcosine in control cells transfected with empty 
vector and in cells transfected with the PEPT 2 cDNA. 
When this construct was transfected into HeLa cells ex- 
pressing a recombinant vaccinia virus T7 RNA poly- 
merase, the cells were able to transport the dipeptide in a 
H +-dependent manner (Fig. 3). The transport in PEPT 2 
cDNA-transfected cells was 4-fold higher than in ceils 
transfected with the vector lacking the cDNA insert. The 
H +-dependence of the cDNA-induced peptide transport 
activity was evident from the significant increase in the 
activity when measured at pH 6.0 instead of pH 8.0. 
However, the activity was unaffected by the pH change in 
control cells. The transport of glycylsarcosine observed in 
control HeLa cells was not carrier-mediated because this 
activity was not saturable. 
We also determined the transport of glycine and proline 
in control and PEPT 2 cDNA-transfected HeLa cells. The 
radiolabel in glycylsarcosine used in transport measure- 
ments was present in the glycyl moiety as well as in the 
sarcosyl moiety. If the dipeptide is hydrolyzed to any 
significant extent during incubation with the cells, trans- 
port of the radiolabel may occur in the form of free amino 
acids mediated by transport systems other than the 
H +/peptide cotransporter. Mammalian kidney is known to 
express H +-coupled transport systems for amino acids 
such as glycine and proline [22,23]. Therefore, in order to 
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Fig. 3. Transport of glycylsarcosine, glycine, and proline in cells trans- 
fected with empty vector and in cells transfected with PEPT 2 cDNA. 
HeLa ceils were transfected with either empty vector (open bars) or PEPT 
2 cDNA (striped bars) and 8-10 h following transfection transport of 
radiolabeled glycylsarcosine (30 #M), glycine (50 nM), or proline (50 
nM) was measured at pH 6.0 or 8.0 using a 3 min incubation period. 
Values are means ___ S.E. 
establish unequivocally that the cloned kidney cDNA is 
indeed a H +/peptide cotransporter, it was necessary to 
compare the transport of glycine and proline in control and 
PEPT 2 cDNA-transfected cells. The results given in Fig. 
3 show that there was no difference in the transport 
activities of these two amino acids in control cells versus 
cDNA-transfected cells, clearly establishing the identity of 
PEPT 2 as a H +-coupled peptide transporter. 
That the kidney clone represents a H +/pept ide cotrans- 
porter is also supported by the substrate specificity of the 
induced transport activity (Table 1). Transport of radiola- 
bel from [14C]glycylsarcosine (30 /zM) induced by PEPT 
1 cDNA (i.e., transport in PEPT 1 cDNA-transfected cells 
minus transport in cells transfected with empty vector) was 
completely inhibitable by excess (10 mM) unlabeled 
dipeptides, tripeptides, and fl-lactam antibiotics. Free 
amino acids had minimal effect on the transport of the 
radiolabel. 
Mammalian kidney and small intestine are the primary 
tissues in which H +-coupled peptide transport activity is 
Table 1 
Substrate specificity of PEPT 2 
Inhibitor [14 C]Gly-Sar transport 
pmol/106 cells per 3 min % 
None 52.6 + 2.5 100 
Glycine 48.3 + 2.0 92 
Sarcosine 46.3 + 3.0 88 
Gly-Sar 0.8 + 0.2 1 
Gly-Phe 0 0 
Ala-Gly-Pro 0 0 
Cyclacillin 0.7 + 0.0 1 
Cephadroxil 0 0 
Cephalexin 0 0 
HeLa cells were transfected with either the empty vector or PEPT 2 
cDNA and 8-10 h following transfection, transport of [14C]glycylsarco- 
sine (30 /xM) was measured at pH 6.0 using a 3 min incubation. 
Concentration f unlabeled amino acids, peptides, and /3-1actam antibi- 
otics was 10 mM. Data represent PEPT 2 cDNA-induced transport, 
calculated by subtracting the transport invector-transfected c lls from the 
transport in PEPT 2 cDNA-transfected cells. In the absence of unlabeled 
compounds, the transport in vector-transfected c lls represented 25+ 3% 
of the transport in PEPT 2 cDNA-transfected ceils. Values are means + 
S.E. 
expressed. Northern analysis of mRNA derived from hu- 
man kidney and intestine with PEPT 2 cDNA as the probe 
failed to detect hybridizable transcripts in these tissues. 
Therefore, we used RT-PCR to determine the expression 
of the PEPT 2 mRNA in the human kidney and small 
intestine. RNA isolated from these tissues was subjected to 
RT-PCR using primers which were specific for PEPT 2 
and the products were analyzed. RNA from human kidney 
produced a PCR product of expected size (~ 0.9 kb) (Fig. 
4). In contrast, RNA from human intestine failed to gener- 
ate this product. These results show that PEPT 2 is specifi- 
cally expressed in the kidney. Small intestine, a major site 
for peptide transport, does not express PEPT 2. The failure 
to detect hybridizing signals in the kidney RNA samples is 
123 456 
0.9 kb -  
---- 1.2 kb 
PEPT 2 PEPT 1 
Fig. 4. Differential expression ofPEPT 1 and PEPT 2 in human intestine 
and kidney. RNA from human intestine (lanes 1 and 4) and human kidney 
(lanes 2 and 5) was subjected to RT-PCR using primer pairs specific for 
either PEPT 1 (lanes 4-6) or PEPT 2 (lanes 1-3). Lanes 3 and 6 are 
negative controls run in parallel in the absence of RNA. The RT-PCR 
products were analyzed by agarose gel electrophoresis. 
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most likely due to low abundance of the transcripts. North- 
ern analysis with PEPT 1 cDNA as the probe has indicated 
previously that, in contrast o PEPT 2, the PEPT 1 tran- 
scripts are present in the small intestine as well as kidney 
[15]. In the present study, we investigated the expression 
of PEPT 1 transcripts in these two tissues by RT-PCR 
using primers pecific for PEPT 1. RNA from both tissues 
produced PCR products of expected size (~ 1.2 kb) (Fig. 
4). It is clear from these experiments hat while PEPT 1 is 
expressed in both intestine and kidney, PEPT 2 is ex- 
pressed only in kidney. 
Studies on peptide transport mechanisms in the kidney 
are of importance for physiologic and pharmacologic rea- 
sons. The transport system plays a significant role in the 
reabsorption of peptides from the tubular filtrate. These 
peptides are those present in the circulation as well as 
those which are generated in the tubular lumen as a result 
of hydrolysis of larger peptides by brush border peptidases 
[24-26]. In addition, peptide-based formulas are being 
considered in place of elemental solutions containing free 
amino acids for parenteral nutrition [27,28]. The ability of 
the kidneys to reabsorb and hydrolyze these peptides may 
become a key determinant in the utility and efficacy of 
such solutions in clinical practice. Moreover, pharmaco- 
logically active peptidomimetic drugs such as 
aminocephalosporins are good substrates for the renal pep- 
tide transport system. Therefore, the half-life of these 
drugs in circulation and hence their therapeutic efficacy 
are influenced by the ability of the kidneys to reabsorb 
them and thus prevent their elimination in the urine. 
Successful cloning of the kidney-specific PEPT 2 cDNA 
makes an important contribution to a better understanding 
of the transport of peptides in the kidney at the molecular 
level. 
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